Clinical Trial Update: A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of 2% topical tofacitinib cream for cutaneous T-cell lymphoma (CTCL) at stages IA-IIA is currently recruiting. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cutaneous T-Cell Lymphoma | Phase 2 | Status: RECRUITING